Trial intelligence / Profile preview

Vitamin E Acetate vs Nitroglycerin for Chronic Anal Fissure

NCT03787030Phase 3Completed

Sponsor
Hospital General Universitario de Elche
Start
Dec 2018
Primary completion
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of alpha-tocopherol in chronic anal fissure (CAF), sponsored by Hospital General Universitario de Elche. Primary endpoint: Pain associated to anal fissure at 8 weeks. Started Dec 2018; status: completed.

02

Drugs

alpha-tocopherol
03

Conditions

chronic anal fissure (CAF)

Beyond the preview

Go deeper on NCT03787030.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03787030.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call